Want to join the conversation?
Specialty biopharmaceutical company $EBS said that its Board of Directors has authorized the management to implement a stock repurchase program for up to $50MM of common stock from time to time on the open market or in privately negotiated transactions. The term of the authorization of the repurchase program is until Dec. 31, 2017.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.